Publication Name	World Journal of Cardiology
Manuscript ID	100886
Country	China

Received	2024-08-29 07:14
Peer-Review Started	2024-08-29 07:14
To Make the First Decision
Return for Revision	2024-12-05 10:18
Revised	2024-12-18 07:27
Second Decision	2024-12-26 02:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-27 10:05
Articles in Press	2024-12-27 10:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-01-10 00:39
Publish the Manuscript Online	2025-01-21 06:56

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Letter to the Editor
Article Title	Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure
Manuscript Source	Unsolicited Manuscript
All Author List	Yi-Fei Zhang, Yu-Xiang Liu and Wu-Xiao Yang
ORCID	Author(s) ORCID Number Yu-Xiang Liu http://orcid.org/0000-0002-4552-9878 Wu-Xiao Yang http://orcid.org/0009-0002-6099-7706
Funding Agency and Grant Number
Corresponding Author	Wu-Xiao Yang, MD, Department of Nephrology, Shanxi Provincial People's Hospital, Shanxi Medical University, No. 29 Shuangtasi Street, Taiyuan 030012, Shanxi Province, China. 13753143192@163.com
Key Words	Sodium-glucose cotransporter 2 inhibitors; Type 2 diabetes mellitus; Heart failure; Diabetic cardiomyopathy; Cardiovascular disease
Core Tip	Sodium-glucose cotransporter 2 inhibitor exert significant effects in patients with type 2 diabetes and heart failure (HF) through multiple mechanisms, including improving blood glucose control, promoting osmotic diuresis, reducing inflammation and oxidative stress, optimizing myocardial energy metabolism, regulating myocardial ion homeostasis, enhancing endothelial function, reducing sympathetic nervous system activity, and alleviating ventricular remodeling. These effects collectively improve cardiac function and prognosis, thereby reducing hospitalization rates and cardiovascular mortality in patients with various types of HF.
Publish Date	2025-01-21 06:56
Citation	<p>Zhang YF, Liu YX, Yang WX. Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure. <i>World J Cardiol</i> 2025; 17(1): 100886</p>
URL	https://www.wjgnet.com/1949-8462/full/v17/i1/100886.htm
DOI	https://dx.doi.org/10.4330/wjc.v17.i1.100886

Full Article (PDF)	WJC-17-100886-with-cover.pdf
Manuscript File	100886_Auto_Edited_012823.docx
Answering Reviewers	100886-answering-reviewers.pdf
Audio Core Tip	100886-audio.mp3
Conflict-of-Interest Disclosure Form	100886-conflict-of-interest-statement.pdf
Copyright License Agreement	100886-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100886-non-native-speakers.pdf
Peer-review Report	100886-peer-reviews.pdf
Scientific Misconduct Check	100886-scientific-misconduct-check.png
Scientific Editor Work List	100886-scientific-editor-work-list.pdf
CrossCheck Report	100886-crosscheck-report.pdf